Bragar Eagel & Squire, P.C. Reminds Phreesia, Inc. (NYSE:PHR) Investors that a Class Action Lawsuit Has Been Filed Against Phreesia and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against Phreesia, Inc. (NYSE:PHR) in the U.S. District Court for the District of Delaware, alleging that the company and its executives made false or misleading statements regarding revenue visibility. The company significantly reduced its FY 2027 revenue guidance from $545-$559 million to $510-$520 million on March 30, 2026, citing weaker pharmaceutical-marketing commitments and reduced visibility in its Network Solutions segment—risks that were not disclosed during the December 8, 2025 earnings call. The stock fell 21-28% following the revised outlook.